1. Home
  2. XOMA vs AUDC Comparison

XOMA vs AUDC Comparison

Compare XOMA & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • AUDC
  • Stock Information
  • Founded
  • XOMA 1981
  • AUDC 1992
  • Country
  • XOMA United States
  • AUDC Israel
  • Employees
  • XOMA N/A
  • AUDC N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • AUDC Telecommunications Equipment
  • Sector
  • XOMA Health Care
  • AUDC Utilities
  • Exchange
  • XOMA Nasdaq
  • AUDC Nasdaq
  • Market Cap
  • XOMA 319.3M
  • AUDC 339.7M
  • IPO Year
  • XOMA N/A
  • AUDC 1999
  • Fundamental
  • Price
  • XOMA $24.26
  • AUDC $11.60
  • Analyst Decision
  • XOMA Strong Buy
  • AUDC Buy
  • Analyst Count
  • XOMA 2
  • AUDC 2
  • Target Price
  • XOMA $72.00
  • AUDC $11.25
  • AVG Volume (30 Days)
  • XOMA 56.4K
  • AUDC 119.0K
  • Earning Date
  • XOMA 03-07-2025
  • AUDC 02-04-2025
  • Dividend Yield
  • XOMA N/A
  • AUDC 1.63%
  • EPS Growth
  • XOMA N/A
  • AUDC 78.82
  • EPS
  • XOMA N/A
  • AUDC 0.50
  • Revenue
  • XOMA $21,606,000.00
  • AUDC $242,176,000.00
  • Revenue This Year
  • XOMA $511.37
  • AUDC $5.02
  • Revenue Next Year
  • XOMA $26.92
  • AUDC $4.31
  • P/E Ratio
  • XOMA N/A
  • AUDC $22.86
  • Revenue Growth
  • XOMA 389.82
  • AUDC N/A
  • 52 Week Low
  • XOMA $21.27
  • AUDC $7.70
  • 52 Week High
  • XOMA $35.00
  • AUDC $14.04
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 40.11
  • AUDC 63.29
  • Support Level
  • XOMA $24.01
  • AUDC $11.01
  • Resistance Level
  • XOMA $27.43
  • AUDC $12.72
  • Average True Range (ATR)
  • XOMA 1.06
  • AUDC 0.49
  • MACD
  • XOMA -0.14
  • AUDC -0.03
  • Stochastic Oscillator
  • XOMA 22.51
  • AUDC 77.14

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

Share on Social Networks: